[PDF][PDF] Selective loss of PARG restores PARylation and counteracts PARP inhibitor-mediated synthetic lethality

…, JA Schmid, R de Bruijn, DI James, SG Llobet… - Cancer cell, 2018 - cell.com
Inhibitors of poly(ADP-ribose) (PAR) polymerase (PARPi) have recently entered the clinic for
the treatment of homologous recombination (HR)-deficient cancers. Despite the success of …

[HTML][HTML] Overexpression of Cyclin E1 or Cdc25A leads to replication stress, mitotic aberrancies, and increased sensitivity to replication checkpoint inhibitors

YP Kok, S Guerrero Llobet, PM Schoonen, M Everts… - Oncogenesis, 2020 - nature.com
Oncogene-induced replication stress, for instance as a result of Cyclin E1 overexpression,
causes genomic instability and has been linked to tumorigenesis. To survive high levels of …

Selective loss of PARG restores PARylation and counteracts PARP inhibitor-mediated synthetic lethality

…, JA Schmid, R de Bruijn, DI James, SG Llobet… - Cancer Cell, 2019 - cell.com
(Cancer Cell 33, 1078–1093. e1–e12; June 11, 2018) In the originally published version of
this article, the red section (> 20%) of the pie chart ‘‘Triple-negative breast cancers’’in Figure …

[HTML][HTML] Cyclin E expression is associated with high levels of replication stress in triple-negative breast cancer

S Guerrero Llobet, B van der Vegt, E Jongeneel… - NPJ breast …, 2020 - nature.com
Replication stress entails the improper progression of DNA replication. In cancer cells,
including breast cancer cells, an important cause of replication stress is oncogene activation. …

An mRNA expression-based signature for oncogene-induced replication-stress

S Guerrero Llobet, A Bhattacharya, M Everts, K Kok… - Oncogene, 2022 - nature.com
Oncogene-induced replication stress characterizes many aggressive cancers. Several
treatments are being developed that target replication stress, however, identification of tumors …

[PDF][PDF] Identification of two protein-signaling states delineating transcriptionally heterogeneous human medulloblastoma

…, TGJ Meeuwsen-de Boer, HJ Lourens, SG Llobet… - Cell reports, 2018 - cell.com
The brain cancer medulloblastoma consists of different transcriptional subgroups. To
characterize medulloblastoma at the phosphoprotein-signaling level, we performed high-…

Replication stress: driver and therapeutic target in genomically instable cancers

PM Schoonen, SG Llobet, MATM van Vugt - Advances in protein chemistry …, 2019 - Elsevier
Genomically instable cancers are characterized by progressive loss and gain of chromosomal
fragments, and the acquisition of complex genomic rearrangements. Such cancers, …

[HTML][HTML] Erratum to: Controlling the response to DNA damage by the APC/C-Cdh1

HR de Boer, SG Llobet, MATM van Vugt - Cellular and molecular life …, 2016 - Springer
Reproduction depends on successful cell division, which is coordinated in the cell cycle.
Especially in the context of multicellular organisms, proper control of cell cycle initiation and …

The RECQL helicase prevents replication fork collapse during replication stress

…, FPA van Gemert, C Lieftink, SG Llobet… - Life science …, 2020 - life-science-alliance.org
Most tumors lack the G1/S phase checkpoint and are insensitive to antigrowth signals. Loss
of G1/S control can severely perturb DNA replication as revealed by slow replication fork …

Exploiting genomic instability as an Achilles' heel in cancer

SG Llobet - 2021 - research.rug.nl
Genomic instability is a hallmark of cancer for which an important cause is the DNA damage
generated by oncogene-induced replication stress (RS). Genomically instable cancers …